阿尔茨海默病患者抗癫痫药物使用与死亡风险
基于芬兰MEDALZ队列(70,718例临床确诊AD),匹配5,638例新启用抗癫痫药者与5,638例非使用者,采用Cox回归和IPTW分析。AED使用者死亡风险增加(IPTW HR 1.23,95%CI 1.12-1.36),主要归因于痴呆相关死亡(HR 1.62,95%CI 1.42-1.86),用药前90天死亡风险最高(HR 2.40,95%CI 1.91-3.03),旧型AED风险高于新型。
要点
- AD患者启用AED后总体死亡风险增加23%,痴呆相关死亡风险增加62%。
- 用药最初90天死亡风险最高(HR 2.40),需加强早期不良事件监测。
- 旧型AED死亡风险高于新型AED(HR 1.79),选药时需权衡。
核心结论
- 社区居住的阿尔茨海默病患者启用抗癫痫药与死亡风险增加相关,主要归因于痴呆相关死亡,旧型AED风险更高。
研究设计与样本
- MEDALZ队列纳入2005-2011年芬兰所有临床确诊AD患者(n=70,718),识别新启用AED者(n=5,638),按性别、年龄和AD确诊时间1:1匹配非使用者,采用Cox比例回归和IPTW分析。
主要发现
- AED使用者较非使用者死亡风险增加(IPTW HR 1.23;95%CI 1.12-1.36)。
- 痴呆相关死亡风险增加(IPTW HR 1.62;95%CI 1.42-1.86),心脑血管死亡无差异(IPTW HR 0.98;95%CI 0.67-1.44)。
- 用药前90天死亡风险最高(IPTW HR 2.40;95%CI 1.91-3.03)。
- 旧型AED使用者死亡风险高于新型AED使用者(IPTW HR 1.79;95%CI 1.52-2.16)。
- 近50%使用者在6个月内停用AED。
关键数值与推荐
- 新启用AED者较非使用者死亡风险增加(IPTW HR 1.23;95%CI 1.12-1.36)。
- 痴呆相关死亡风险增加(IPTW HR 1.62;95%CI 1.42-1.86)。
- 用药前90天死亡风险最高(IPTW HR 2.40;95%CI 1.91-3.03)。
- 旧型AED较新型AED死亡风险更高(IPTW HR 1.79;95%CI 1.52-2.16)。
临床怎么用
- 对认知障碍老年患者启用AED需谨慎评估,并密切监测不良事件。
- 优先考虑新型AED可能降低死亡风险,但需个体化权衡。
- 用药初期尤其是前90天应加强随访和不良反应监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the risk of death in relation to incident antiepileptic drug (AED) use compared with nonuse in people with Alzheimer disease (AD) through the assessment in terms of duration of use, specific drugs, and main causes of death. METHODS: The MEDALZ (Medication Use and Alzheimer Disease) cohort study includes all Finnish persons who received a clinically verified AD diagnosis (n = 70,718) in 2005-2011. Incident AED users were identified with 1-year washout period. For each incident AED user (n = 5,638), 1 nonuser was matched according to sex, age, and time since AD diagnosis. Analyses were conducted with Cox proportional regression models and inverse probability of treatment weighting (IPTW). RESULTS: Nearly 50% discontinued AEDs within 6 months. Compared with nonusers, AED users had an increased relative risk of death (IPTW hazard ratio [HR], 1.23; 95% confidence interval [CI], 1.12-1.36). This was mainly due to deaths from dementia (IPTW HR, 1.62; 95% CI, 1.42-1.86). There was no difference in cardiovascular and cerebrovascular deaths (IPTW HR, 0.98; 95% CI, 0.67-1.44). The overall mortality was highest during the first 90 days of AED use (IPTW HR, 2.40; 95% CI, 1.91-3.03). Among users of older AEDs, relative risk of death was greater compared to users of newer AEDs (IPTW HR, 1.79; 95% CI, 1.52-2.16). CONCLUSION: In older vulnerable patients with a cognitive disorder, careful consideration of AED initiation and close adverse events monitoring are needed.
引用
- Court T, Lavikainen P, Taipale H, et al. Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease. Neurology. 2020. PMID: 32327491. doi:10.1212/WNL.0000000000009435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。